Molecular simulation to aid in the understanding of the Aβ(1-42) peptide of Alzheimer's disease

Molecular Simulation

Volumn 26, Issue 6, 2001, Pages 367-379

  Mager, Peter P ^a   Reinhardt, Robert ^a   Fischer, Katrin ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Aggregation of peptides; Amyloid; A peptides; Conformational transitions; Drug; Hydrophobic cores of sheets; Molecular simulation; Morbus Alzheimer; helix; sheet

Indexed keywords

EID: 0346488919     PISSN: 08927022     EISSN: None     Source Type: Journal    
DOI: 10.1080/08927020108024511     Document Type: Article

References (33)

1. Allinger, N. L. and Yan, L. (1993). Molecular mechanics (MM3). Calculation of furan, vinyl, ethers, and related compounds, J. Am. Chem. Soc., 115, 11918-11925.
2. Alvarez, A., Alarcon, R., Opazo, C., Campos, E. O., Munoz, F. J., Calderon, F. H., Dajas, F., Gentry, M. K., Doctor, B. P., De Mello, F. G. and Inestrosa, N. C. (1998). Stable complexes involving acetylcholinesterase and amyloid-β peptide change the biochemical properties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils, J. Neurosci., 18, 3213-3223.
3. Barrow, C. J., Kenny, P. T. M., Ykikazu, A. and Zagorski, M. G. (1992). Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease, J. Mol. Biol., 225, 1075-1093.
4. Böhm, H.-J. (1993). Ab initio SCF calculations on low-energy conformers of N-acetylglycine N′-methylamide, J. Am. Chem. Soc., 115, 6152-6158.
5. Butterfield, D. H., Aksenov, M., Aksenova, M., Carney, J. M., Cole, P., Hall, N., Harris, M. E., Hensley, K., Howard, B. J., LaFontaine, M., Subramaniam, R. and Yatin, S. (1997). β-amyloid-derived free radical oxidation: a fundamental process in Alzheimer's disease, In: Molecular Mechanisms of Dementia, Wasco, N. and Tansi, R. E. Eds., Human Press, Totowa, NJ, pp. 145-167.
6. Coles, M., Bicknell, W., Watson, A. A., Fairlie, D. P. and Craik, D. J. (1998). Solution structure of amyloid β-peptide (1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry, 37, 11064-11077.
7. Forsman, J., Jönsson, B., Woodward, C. E. and Wennerstrom, H. (1997). Attractive surface forces due to liquid density depression, J. Phys. Chem. Ser. B, 101, 4253-4259.
8. Frey R. F., Cheng, V. K. W., Coffin, J., Momany, F. A., Newton, M., Ramek, S. Q. and Schäfer, L. (1992). Importance of correlation-gradient geometry optimization for molecular conformational analyses, J. Am. Chem. Soc., 114, 5369-5377.
9. Ganta, J., Shen, C. L., Kissling, L. L. and Murphy, R. M. (1996). A strategy for designing inhibitors of β-amyloid toxicity, J. Biol. Chem., 271, 29525-29528.
10. Gasteiger, J. and Marsili, M. (1980). Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges, Tetrahedron, 36, 3219-3288.
11. Hilbich, C., Beyreuther, K., Hilbich, C., Kisters-Wolke, B., Masters, C. L. and Reed, J. (1991). Aggregation and secondary structure of synthetic amyloid βA4 peptide of Alzheimer's disease, J. Mol. Biol., 218, 149-163.
12. Hunter, C. A. (1994). The role of aromatic interactions in molecular recognition, Chem. Soc. Rev., pp. 101-1094.
13. John, V., Latimer, L. H., Tung, J. S. and Dappen, M. S. (1997). Alzheimer's disease: recent advances on the amyloid hypothesis, Annu. Rep. Med. Chem., 32, 11-20.
14. Kortemme, T., Ramirez-Alvarado, M. and Serrano, L. (1998). Design of a 20-amino acid, three-stranded β-sheet protein, Science, 281, 253-256.
15. Mager, P. P. (1998). Molecular simulation of the amyloid β-peptide Aβ(1-40) of Alzheimer's disease, Mol. Simul., 20, 201-222.
16. Mori, H., Ogawara, M., Selkoe, D. J. and Takio, K. (1992). Mass spectrometry of purified amyloid β protein in Alzheimer's disease, Biol. Chem., 267, 17082-17806,
17. Pedersen, W. A., Kloczewiak, M. A. and Blusztajn, J. K. (1996). Amyloid β-protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain, Proc. Natl. Acad. Sci. USA, 93, 8068-8071.
18. Perzel, A., Csaszar, P., Czizmadia, G. and McAllister, M. A. (1993). Peptide models, 6. New β-turn conformations from ab initio calculations confirmed by X-ray data of proteins, J. Am. Chem. Soc., 155, 4849-4858.
19. Prelli, F., Bots, G. T. A. M., Castano, E. M., van Duinen, S. G., Frangione, B. and Luyendijk, W. (1988). Differential processing of Alzheimer's β-protein precursor in the vessel wall of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type, Biochem. Biophys. Res. Commun., 151, 1150-1155.
20. Sreerama, N. and Woodey, R. W. (1993). A self-consistent method for the analysis of protein secondary structure from circular dichroism, Anal. Biochem., 209, 32-44.
21. Shao, H., Marcinowski, K. J., Clancy, E. L., Salomon, A. R. and Zagorski, M. G. (1997). The solution structures of the β-amyloid peptide provide a molecular approach for the treatment of Alzheimer's disease, In: Alzheimer's Disease: Biology, Diagnosis and Therapeutics, Eds., Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. and Wisniewski, H. M., Wiley, New York, pp. 729-735.
22. Simmonis, L. W., Becker, G. W., Brems, D. N., Brigham, E. F., Fuson, K. S., Li, W. Y., Lieberburg, I., May, P. C., Reydel, R. E., Tomaselli, K. J. and Wright, S. (1994). Secondary structure of amylod β peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol., 45, 373-379.
23. Smith, C. K. and Regan, L. (1997). Construction and design of β-sheets, Acc. Chem. Res., 30, 153-161.
24. Soto, C., Kindy, M. S., Baumann, M. and Frangione, B. (1996). Inhibition of Alzheimer's amyloidosis by peptides that prevent β-sheet conformation, Biochem. Biophys. Res. Commun., 226, 672-680.
25. Soto, C. and Frangione, B. (1997). Inhibition of Alzheimer's amyloidogenesis by anti-β-sheet peptides, In: Alzheimer's Disease: Biology, Diagnosis and Therapeutics, Eds., Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. and Wisniewski, H. M., Wiley, New York, pp. 711-716.
26. Tai, J. C., Allinger, N. L. and Yang, L. (1993). Molecular mechanics (MM3). Calculation on nitrogen-containing aromatic heterocyclics, J. Am. Chem. Soc., 115, 11906-11917.
27. Terzi, E., Holzemann, G. and Seelig, J. (1994). Alzheimer beta-amyloid peptide 25-35: electrostatic interactions with phospholipid membranes, Biochemistry, 33, 7431-7441.
28. Tjernberg, L. O., Näslund, J., Lindqvist, F., Johansson, J., Karlström, A. R., Thyberg, J., Terenius, L., and Nordstedt, C. (1996). Arrest of β-amyloid fibril formation by a pentapeptide ligand, J. Biol. Chem., 271, 8545-8548.
29. Venkatachalam, C. M. (1968). Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units, Biopolymers, 6, 1425-1436.
30. Williams, M. P., Puttfarcken, P. and Shiosaki, K. (1995). Amyloid β peptide in Alzheimer's disease pathology: towards a rational basis for drug discovery? Exp. Opin. Invest. Drugs, 4, 263-270.
31. Chauhan, A., Ray, I. and Chauhan, V. P. (2000). Interaction of amyloid β-protein with anionic phospholipids: possible involvement of Lys28 and C-terminus aliphatic amino acids, J. Neurochem., 25, 423-429.
32. Schenk, D. B., Seubert, P., Lieberburg, I. and Wallace, J. (2000). β-peptide immunization: a possible new treatment for Alzheimer's disease, Arch. Neurol., 57, 934-936.
33. Wang, H. Y., Lee, D. H., Davis, C. B. and Shank, R. P. (2000). β-amyloid (1-42) binds to α7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology, J. Biol. Chem., 275, 5626-5632.